Label: BIODESP DM NF- dextromethorphan hbr, guaifenesin, phenylephrine hcl liquid

  • NDC Code(s): 45737-263-16
  • Packager: Advanced Generic Corporation
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: OTC monograph final

DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Drug Label Information

Updated December 23, 2020

If you are a consumer or patient please visit this version.

  • ACTIVE INGREDIENT

    Active Ingredients (in each 5mL)                              Purpose

    Dextromethorphan HBr, 10 mg ................................. Cough Suppressant

    Guaifenesin, 100 mg ................................................ Expectorant

    Phenylephrine HCl, 5 mg ...................................... Nasal Decongestant

  • PURPOSE

    Purpose

    Cough Suppressant

    Expectorant

    Nasal Decongestant

  • INDICATIONS & USAGE

    Uses

    • temporarily relieves these symptoms due to the common cold, hay fever (allergic rhinitis), or other upper respiratory allergies:
    • cough due to minor throat and bronchial irritation
    • helps loosen phlegm (mucus) and thin bronchial secretions to drain bronchial tubes and make coughs more productive
    • nasal congestion
    • reduces swelling of nasal passages
  • WARNINGS

    Warnings:

    Do no exceed recommended dosage

    • A persistent cough may be a sign of a serious condition. If cough persists for more than 1 week, tends to recur or is accompanied by a fever, rash or a persistent headache, consult a doctor

    Do not use this product if you

    are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric or emotional condition. or for two weeks after stopping the MAOI drug. If you do not know if your prescription drug contains a MAOI, ask a doctor or phamacist before taking thie product.

    Ask a doctor before use if you have

    • a persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema, or where cough is accompanied by excessive phlegm (mucus) unless directed by a doctor.
    • high blood pressure
    • heart disease
    • thyroid disease
    • diabetes
    • difficulty in urincation due to enlargment of the prostate gland unless directed by a doctor

    Stop use and ask a doctor if

    • nervousness, dizziness, or sleeplessness occur
    • if symptoms do not improve within 7 days or are accompanied by fever

    Ask a doctor before use if you are taking sedatives or tranquilizers

  • KEEP OUT OF REACH OF CHILDREN

    Keep out of the reach of children.In case of accidental overdose, get medical help or contact a Poison Control Center immediately.

  • PREGNANCY OR BREAST FEEDING

    If pregnant or breast-feeding, ask a doctor before use

  • DOSAGE & ADMINISTRATION

    Directions: take every 4 hours, not to exceed 6 doses in 24 hours or as directed by a doctor.

    AgeDose
    Adults and children 12 years of age and over2 teaspoonfuls (10 mL) every 4 hours
    Children 6 to under 12 years of age1 teaspoonful (5 mL) every 4 hours
    Children under 6 years of age1/2 teaspoonful (2.5 mL) every 4 hours to consult a doctor

  • INACTIVE INGREDIENT

    Inactive ingredients: citric acid, flavor, menthol, methylparaben, propylene glycol, propylparaben, pruified water, sodium citrate, and sucralose.

  • QUESTIONS

    Questions or comments? 1-305-403-3788

  • PRINCIPAL DISPLAY PANEL

    BiodespDMNF

  • INGREDIENTS AND APPEARANCE
    BIODESP  DM NF
    dextromethorphan hbr, guaifenesin, phenylephrine hcl liquid
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:45737-263
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    DEXTROMETHORPHAN HYDROBROMIDE (UNII: 9D2RTI9KYH) (DEXTROMETHORPHAN - UNII:7355X3ROTS) DEXTROMETHORPHAN HYDROBROMIDE15 mg  in 5 mL
    GUAIFENESIN (UNII: 495W7451VQ) (GUAIFENESIN - UNII:495W7451VQ) GUAIFENESIN100 mg  in 5 mL
    PHENYLEPHRINE HYDROCHLORIDE (UNII: 04JA59TNSJ) (PHENYLEPHRINE - UNII:1WS297W6MV) PHENYLEPHRINE HYDROCHLORIDE5 mg  in 5 mL
    Inactive Ingredients
    Ingredient NameStrength
    ANHYDROUS CITRIC ACID (UNII: XF417D3PSL)  
    MENTHOL (UNII: L7T10EIP3A)  
    METHYLPARABEN (UNII: A2I8C7HI9T)  
    PROPYLPARABEN (UNII: Z8IX2SC1OH)  
    PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
    WATER (UNII: 059QF0KO0R)  
    SUCRALOSE (UNII: 96K6UQ3ZD4)  
    SODIUM CITRATE (UNII: 1Q73Q2JULR)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:45737-263-16473 mL in 1 BOTTLE; Type 0: Not a Combination Product03/01/2015
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC monograph finalpart34103/01/2015
    Labeler - Advanced Generic Corporation (831762971)